Open access peer-reviewed chapter

Breast Reconstructive Options

Written By

Benjamin Liliav and Luis Torres-Strauss

Submitted: 05 November 2022 Reviewed: 08 November 2022 Published: 06 December 2022

DOI: 10.5772/intechopen.108945

From the Edited Volume

Breast Cancer Updates

Edited by Selim Sözen and Seyfi Emir

Chapter metrics overview

75 Chapter Downloads

View Full Metrics

Abstract

Breast reconstructive options have evolved over the past six decades. Despite advancements in technology, improved therapeutic options, and genetic testing, women are still, unfortunately, faced with a myriad of deformities after treatments for breast cancer. In order to restore an esthetically pleasing breast mound, a careful evaluation of the patient must be taken into account. There are, generally, three components or factors that need to be considered while devising an excellent reconstructive option for a particular patient. These are: patient factors, surgeons’ factors, and oncologic factors. It is only with a detailed understanding of each one of these factors that a sound solution is arrived at. In this chapter, we will explore the various modalities of breast reconstruction available to patients. We will also demonstrate specific considerations in order to optimize an excellent outcome for our breast cancer patients.

Keywords

  • breast reconstruction
  • breast cancer
  • implant based reconstruction
  • autologous reconstruction
  • lipofilling of breast
  • fat grafting breast
  • advances
  • and trends in reconstruction of the breast

1. Introduction

Breast cancer (BC) is the most common cancer of women in the United States and worldwide [1, 2]. The management of BC is in constant evolution. Multiple landmark studies published in the last several decades have led to a transition from a more radical surgical approach towards breast conserving surgery and less deforming mastectomies [3, 4, 5, 6, 7] (Figure 1). Similarly, the field of breast reconstruction (BR) has seen many changes in the form of new knowledge and technical advancements that have led to the development of modern reconstructive practices for restoration of a breast mound.

Figure 1.

Evolution of breast cancer surgery.

The surgical treatment of BC is best achieved in a multidisciplinary approach [8, 9, 10]. The patient typically requires the expertise of many medical and surgical specialists as part of their collaborative treatment plan. Adjuvant therapies in the form of chemotherapy, radiation therapy, hormonal therapy, biologic therapy, and psychologic therapies, may be required for optimal treatment of BC patients. For those undergoing a surgical treatment, reconstruction should be an integral part of the treatment plan as well. The goal of BR is to restore an esthetically pleasing breast mound. With many recent advancements in knowledge and surgical techniques, the ability to restore a cosmetically appealing breast utilizing BR has evolved into its modern practice.

The female breast is the most revered symbol of femininity. From physiological stand point, the breasts main function is lactation. From an anatomical perspective, they serve as a crucial part of the female body image and sexuality [11]. Breast oncologic surgery for the treatment of BC may lead to anatomic deformities with the consequence of adverse impact on the patient’s quality of life [12]. Many studies have shown the psychologic and therapeutic benefits in women who undergo BR [13]. The breast restoration experience has been shown not only to reinstate the esthetically pleasing breast but also to improve the personal body image in these women [14].

When a BC patient undergoes a surgical treatment for a tumor, it may result in breast deformities or the complete acquired absence of a breast.

With breast conserving therapy, which entails lumpectomy and radiation, several breast contour deformities and volume distortion may result from tumor excision and radiation treatment (Figure 2) [15, 16].

Figure 2.

48 year old female after lumpectomy and radiation to her right breast. Volume distortion and contour abnormality is clearly visible in the right breast compared with left.

In patients undergoing mastectomy either as a Skin Sparing Mastectomy (SSM) or a Nipple Sparing Mastectomy (NSM), the result is a patient with acquired breast absence (Figure 3). In order to offset these deformities, and optimize the surgical outcome, the patient should be informed of reconstructive options prior to undergoing the lumpectomy or mastectomy procedures. Therefore, it is absolutely imperative to involve the reconstructive plastic surgeon as part of the multidisciplinary team as soon as the diagnosis for BC is made. This will allow the patient to have access to and be carefully evaluated by the reconstructive plastic surgeon and help determine what breast restoration options are available to the patient early in the treatment process.

Figure 3.

32 year old female after right mastectomy with total acquired breast absence.

Advertisement

2. Options for breast cancer surgery

  • Conservative treatment (lumpectomy +radiation)

    In some cases, Oncoplastic surgery.

  • Mastectomy

    Modified radical, Skin Sparing, Nipple Sparing

    1. With Reconstruction

      1. Autologous Tissue

      2. Implant based reconstruction

      3. Fat grafting

    2. Without Reconstruction

  • Contralateral Breast surgery

Advertisement

3. Considerations in breast reconstruction

There are three different factors that must be considered while choosing a BR option. These are patient related factors, Oncologic factors, and surgeon related factors. The plan must be individualized to each patient based on these factors. Furthermore, the decision process of reconstructive procedure must entail a collaborative approach between the plastic surgeon and the affected patient [17]. More specifically, the reconstructive plastic surgeon presents the available options based on the above mentioned factors, while the patient states her desires to finally arrive at the optimal breast reconstructive plan.

Patient related factors are: the age of the patient, the patient’s desires, overall health and comorbidities, previous breast or other body surgeries, smoking history, and patient anatomy. Oncologic factors involve BC history, history of radiation therapy, history of breast biopsies, tumor biological features, and the potential need for adjuvant chemotherapy, radiation therapy, biological and hormonal therapy. Surgeon related factors include the availability of a plastic surgeon to perform a particular reconstruction, and optimal facility with appropriate capabilities and ancillary staff where the surgery will be performed.

Advertisement

4. Who is a candidate for BR after BC surgery?

Most women diagnosed with BC are candidates for BR which is viewed as part of the healing process. Every patient, regardless of disease stage, socioeconomic status, or demographics, must be informed about options and techniques available to them. Historically, there was a concern that BR may mask locoregional recurrence or that it may compromise adjuvant treatments [18]. However, the available evidence suggest that BR does not adversely affect disease-free or overall survival and there is no significant delay in recurrent disease presentation [19]. Currently, with improved social media and internet access, there is an increase in frequency of patients who are desiring breast reconstruction after mastectomy [20].

The multidisciplinary team should review important parameters in order to obtain a complete evaluation of any particular patient (Figure 4).

Figure 4.

Breast reconstruction patient’s criteria.

There is a particular group of patients who is considered high risk based on genetic mutations. Less than 15%of all BC are associated with germline mutations [21]. The majority of hereditary breast tumors are due to mutations in BrCa1 and/or BrCa2 genes, these patients often have bilateral and multicentric disease, early-onset, and more likely to be Triple Negative (ER-, PR-, HER2-) [22, 23]. One of the most effective strategies in treating these women is the prophylactic mastectomy better defined as Risk Reduction mastectomy (RRM). This technique provided the greatest reduction in risk of BC development (around 90%) and also diminishes the anxiety and fear in these affected women [24]. As a result of that, this subset of patients can benefit from prophylactic mastectomy, and require breast reconstruction of their affected breast as well as a restoration procedure for their contralateral breast. It should be noted that contralateral RRM does not improve survival in patients without deleterious genetic mutations or lobular histology [25]. In the USA, a growing rate of bilateral mastectomy for unilateral BC is being observed. Availability of immediate BR, young age, pathogenic BrCa mutations, significant family history, and Triple Negative disease play a significant role in choosing this type of surgery. NSM plus immediate BR is nowadays considered the gold standard in this group of women [26].

Advertisement

5. No reconstruction

Some patients prefer not to have BR and opt for a breast prosthesis instead. The advantage of this device is not taxing the body with additional surgery other than the required oncologic procedure. The disadvantages are significant discomfort, skin irritation and rashes, and inability to wear a bathing suit or clothing comfortably. This option is reasonable for an elderly patient who is not concerned about cosmesis or a patient with many comorbidities who is not a candidate for BR.

Advertisement

6. Delayed reconstruction

A delayed BR is breast restoration performed at a later date as an independent separate procedure by the plastic surgeon. The patient initially undergoes the oncologic procedure with a mastectomy or breast conserving therapy. Subsequently, the patient pursues Breast reconstruction based on a collaborative approach with the plastic surgeon. This reconstructive option is ideal if there is no availability of plastic surgeon at the facility or if negative margins could not be achieved during the oncologic procedure. Once the patient is cleared from an oncologic standpoint, the BR can be pursued at a later date. Advantages include allowing time to identify a board certified plastic surgeon who will perform the reconstruction at a nearby facility as well as appropriate allotted time for oncologic treatment in terms of achieving final negative margins. The disadvantage of this approach is that by waiting, the patient endures the negative psychologic implications of not having a breast or having a deformed breast until the reconstruction is performed. In addition, with delayed reconstruction there is scarring and fibrosis that forms as part of the healing process that may impact the type of reconstruction that can be performed at a later date [27, 28].

Advertisement

7. Implant based reconstruction (IBR)

IBR entails using a breast implant (silicone or saline) to create a breast mound after mastectomy. The advantages of IBR are that this procedure is relatively simple, expedient, and has short recovery time. The disadvantages are implant related complications such as implant rupture, exposure, extrusion, and capsular contractures [29]. IBR can be performed in a single or two stage technique. In a single stage IBR, the plastic surgeon places the breast implant to reconstruct the breast mound at the same operation immediately after mastectomy [30]. Alternatively, IBR can be performed in two stages. This is particularly useful in cases where extra skin needs to be recruited. In this approach, a tissue expander is placed first at the time of mastectomy. The device is expanded over time on a weekly basis in the medical office. Several months later, the second stage of the procedure is performed where the tissue expander is removed and replaced with a permanent breast implant [31].

Irrespective of single or two stage implant reconstruction technique, anatomically, these devices (expander and/or implant) can be placed either above or below the pectoralis muscle. In the early period of breast reconstruction, pre-pectoral (above the pectoralis muscle) implant placement was abandoned due to high rates of capsular contracture, implant extrusion and poor esthetic results. Subsequently, the shift to subpectoral plane (under the pectoralis muscle) offered an increased coverage of the implant and less of the above implant related complications However, over the years it became apparent that submuscular implant placement is associated with chronic muscle related pain, muscle spasms, animation deformity, and reduced physical mobility. With optimization of mastectomy technique, advances in radiotherapy, use of alloplastic devices, fat grafting, and new implant designs, the prepectoral approach has undergone a revival and is now performed in many centers around the world [32].

With certain surgical advancements, oncologic surgeons are transitioning to SSM and NSM. Technological breakthrough has contributed to the availability of mesh (Human/animal/synthetic) for reconstructive support [33]. Improvements in the breast implant device characteristics have led to improved outcomes for patients undergoing IBR as well. Furthermore, due to these advances in mastectomy techniques, and the recent increase in bilateral mastectomies performed, IBR is the most common approach currently used for breast reconstruction. According to The American Society of Plastic Surgeons 2018 publication, 40% of women who underwent mastectomy had reconstruction and the most common practice in the US was immediate reconstruction (75% of the cases) of these 81% corresponded to Implant based (two-stage 68%, one stage 13% (Figures 5 and 6) [34].

Figure 5.

36 year old female with history of bilateral SSM and immediate subpectoral implant based BR. Of note she also had bilateral nipple reconstruction.

Figure 6.

28 year old female with history of BRCA gene mutation. Left: demonstrates her pre surgery (pre mastectomy). Right: patient 6 months after Bilateral prophylactic NSM with immediate prepectoral implant based BR.

Advertisement

8. Autologous breast reconstruction (AR)

The premise in AR is utilizing tissue such as skin, fat, and sometimes muscle from another place on the patient’s body in order to create a breast mound. AR can be performed in immediate or delayed fashion as well [35]. Many different types of flaps have been described in the literature for restoration of breast mound using patients own body tissues [36]. Some are abdominal based flaps (TRAM, DIEP, SIEA), others are gluteal based flaps (SGAP, IGAP), there are thigh based flaps (PAP, TUG) and back based flaps (LD, TDAP) [37]. Most of these flaps require a microsurgeon who is well versed in microsurgical techniques, the availability of a microscope, a well-trained surgical team in microsurgery, and a facility that can support these types of complex and delicate operations. The advantages of BR using these flaps are natural appearing results, esthetically pleasing outcome, and improved patient satisfaction [38]. The disadvantages are the need for a skilled microsurgeon, long procedure time, longer recovery period, extra scarring in the donor sites, and increased pain. Figures 710 show examples of Autologous Breast reconstruction.

Figure 7.

Top: 39 year female diagnosed with left breast cancer. Bottom: after Left NSM and reconstruction with abdominal based flap.

Figure 8.

49 year old female with history of right breast cancer. Patient underwent autologous reconstruction with abdominal based flap. Left: right breast reconstruction with DIEP (deep inferior epigastric perforator) flap. Right: same patient after nipple reconstruction.

Figure 9.

Left: 38 years old female diagnosed with invasive right breast cancer. Right: same patient after right NSM and reconstruction with TUG (transverse upper gracilis) flap.

Figure 10.

Patient with history of bilateral breast cancer, right invasive ductal and left lobular in situ. She is shown after bilateral SSM and immediate reconstruction with bilateral LD (latissimus Dorsi) flaps. Delayed tattooing nipple reconstruction.

Advertisement

9. BR with lipofilling

BR could be achieved by lipofilling (fat transfer) after mastectomy. This technique involves removing fat from certain areas in the body by way of liposuction, processing the fat cells, and transferring them to the area of absent breast. It is important to note that there is a limitation of how much fat can be injected in order for the fat cells to survive and often times this requires several sessions of fat grafting in order to obtain the desired result. Patients who undergo breast conserving therapy with lumpectomy resulting in a contour deformity or volume deficiency after excision, may benefit from fat transfer procedure in order to restore the loss of volume in the treated breast [39]. Of note, BR with lipofilling has been shown to be ontologically safe [40]. Advantages of lipofilling for breast reconstruction include the creation of a breast with a natural consistency, minimal scarring, could be use in patients with comorbidities, relatively simple procedure, and low costs [41]. The main limiting factor of this technique is that fat transfer uptake may require multiple fat grafting sessions [42]. This procedure is better offered to patients with small brassiere cup. Some teams report the use of a skin expansion with expander or an expansion device like BRAVA system [43]. Although BR with lipofilling is a relatively new technique, it is gaining in popularity in the United States and worldwide (Figure 11) [44].

Figure 11.

BR with lipofilling. Left: Patient with history of NSM for left BC resulting in contour deformity. Right: patient after Reconstruction with 4 sessions of lipofilling and scar release.

Advertisement

10. Oncoplastic breast reconstruction

In certain BC patients, particularly if they have larger breast size, it is oftentimes possible for them to have the excision of the tumor and have the plastic surgeon perform local breast tissue rearrangement by either lifting the breast or reducing the total size of the breast at the same time that the tumor is being removed. This technique is ideal for a patient with large ptotic breasts who desires breast reduction or lift at the same time of oncologic excision surgery. The advantages are that the tumor is removed with very wide margins and once the tissues are rearranged by way of lifting or reduction, the new breast mound appears even more esthetically pleasing then prior to the patient undergoing surgery. The disadvantages are that the contralateral breast which is not affected from oncologic standpoint is undergoing a surgical procedure as well. Also, many patients are not candidates for this technique especially if their breasts are too small or if the tumor is not in a favorable location (Figure 12) [45, 46].

Figure 12.

46 year old female diagnosed with left invasive breast cancer. Left: preoperative photos. Right: patient after Oncoplastic Surgery with excision of left breast tumor with concurrent bilateral breast reduction.

11. Approach to the opposite breast

Many BC patients who undergo surgical treatment with or without reconstruction oftentimes require treatment to their contralateral breast. The main reason is for symmterization of both breasts and to improve the esthetic outlook. Depending on what treatment is indicated, the contralateral breast may require breast augmentation with implant, breast reduction, or breast lift. When speaking with the BC patients, it is important to make sure they are aware that reconstruction is a process. We must clearly inform the patient not only about the reconstructive options but also symmetrizing procedures that may be needed either at the same time as BR or later on as a separate procedure.

12. Breast implant associated illness

Although rare, it must be mentioned that there are several cases of Breast Implant illness reported in the literature. As of April 1, 2022 The Food and Drug Administration has received a total of 1130 US and global medical device reports of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) [47]. These cases, must be confirmed by pathology/cytology test or Anaplastic Lymphoma Kinase and CD30 biomarkers. More recently, Sept, 2022, the FDA released a new safety communication about Squamous cell carcinoma and various lymphomas in the capsule around breast implants. The current data is limited but evolving. More studies are required to ascertain the magnitude of these findings. Nonetheless, clinical awareness is paramount [48].

13. The impact of post mastectomy radiation therapy on breast reconstruction

Radiation Therapy (RT) is delivered to those patients who are at high risk for developing local recurrence. Indications for radiation therapy include patients undergoing breast conservative surgery as well as patients who undergo mastectomy based on the stage of the tumor and the extent of lymph node metastasis [49]. The need for radiation therapy may not be known until the final pathologic classification of the tumor is completed. Therefore, the reconstructive surgical technique, whether implant based or autologous, should remain the same even in patient who will require post mastectomy radiation therapy. Despite reported data of potential increase in surgical and wound related complications in IBR and to a lesser extent Autologous reconstruction, current literature suggests that there are no absolute contraindications for implant based reconstructions in the setting of post mastectomy radiation therapy [50].

14. Nipple areola reconstruction

Nipple areolar reconstruction (NAR) is the final stage of the breast reconstructive process. The individual who requires NAR is a patient that underwent SSM where the nipple areolar complex is excised as part of the oncologic procedure. In addition, any patient who undergoes NSM, but the nipple areolar complex was compromised due to poor vascularity is a candidate for NAR as well. NAR can be performed as an outpatient procedure under local anesthetic and yields superb results for the patients. Many different techniques are described in the literature for NAR [51]. The authors favorite technique is single stage NAR and tattooing (Figure 13) [52].

Figure 13.

Left: 35 year old female after nipple areolar complex Reconstruction and tattooing in a single stage technique. Right: same patient with side photo showing adequate projection of nipple.

Conflict of interest

The authors declare no conflict of interest.

References

  1. 1. American Cancer Society, CA: A Cancer Journal for Clinicians. The Facts and Figures 2022
  2. 2. World Health Organization. Breast Cancer Fact Sheets. 2021
  3. 3. Fisher B, Redmond C, Poisson R, Margolese R, Wolmark N, Wickerman L, et al. Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. The New England Journal of Medicine. 1989;320:822-828. DOI: 10.1056/NEJM198903303201302
  4. 4. Veronesi U, Salvadori B, Luini A, Banfi A, Del Vecchio M, Saccozzi R, et al. Conservative treatment of early breast cáncer. Long-term resuls of 1232 cases treated with qudrantectomy, axillary dissection and radiotherapy. Annals of Surgery. 1990;211:250-259
  5. 5. Lichter AS, Lippman ME, Danforth DN, et al. Mastectomy versus brest-conserving therapy in the treatment of stage I and II carcinoma of the breast: A randomized trial at the National Cancer Institute. Journal of Clinical Oncology. 1992;10:976-983. DOI: 10.1200/JCO.1992.10.6.976
  6. 6. Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, et al. Twenty-year follow-up f a randomized trial comparing total mastectomy, lumpectomy ad lumpectomy plus irradiation for the treatment of invasive breast cancer. The New England Journal of Medicine. 2002;347:1233-1241. DOI: 10.1056/NEJMoa022152
  7. 7. Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, et al. Twenty-year follow-up off a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. The New England Journal of Medicine. 2002;92:1143-1150. DOI: 10.1056/NEJMoa0220989
  8. 8. Cevik J, Hunter-Smith D, Rozen W. Current Advances in breast reconstruction. Journal of Clinical Medicine. 2022;11(12):3328. DOI: 10.3390/jcm11123328
  9. 9. Pan E-SB, Sosin M, Carey JN, Nahabedian MY, Km P. Breast Reconstruction and adjuvant therapy: A systematic review of surgical outcomes. Surgical Oncology. 2015;112(5):458-464
  10. 10. Kaidar-Person O, Offersen B, Boersma L, Ruysscher D, Tramm T, Kuhn T, et al. A multisciplinary view of mastectomy and breast reconstruction: Understanding the challenges. Breast. Apr 2021;56:42-52. DOI: 10.1016/jbreast.2021.02.004
  11. 11. Shashanka M. Breast Cancer Comprehensive Management. 2022. Chapter 22; p.465-495 DOI: 10.1007/978-981-16-4546-4
  12. 12. Al-Hilli Z, Wilkerson A. Breast surgery: Management of postoperative complications following operations for breast cancer. Surgical Clinics North America. 2021;101(5):845-863. DOI: 10.1016/j.suc.2021.06.014
  13. 13. Planchal H, Matros E. Current trends in post-mastectomy breast reconstruction. Plastic and Reconstructive Surgery. 2017;140(5):7S-13S. DOI: 10.1097/PRS.000000000003941
  14. 14. Zehra S, Doyle F, Barry M, Walsh S, Kell MR. Health-related quality of life following breast reconstruction compared to total mastectomy and breast-conserving surgery among breast cancer survivors: A systematic review and meta-analysis. Breast Cancer. 2020;27(4):534-566. DOI: 10.1007/s12282-020-01076-1
  15. 15. Dahlback C, Ringberg A, Manjer J. Aesthetic outcome following breast-conserving surgery assessed by three evaluation modalities in relation to health-related quality of life. The British Journal of Surgery. 2019;106(1):90-99. DOI: 10.1002/bjs.10963
  16. 16. Deutinger M, Tairych G, Resch A, Biber E. Contour defects after breast preserving therapy of breast carcinoma. Primary and secondary possibilities of correction. Strahlentherapie und Onkologie. 1999;175(11):577-582. DOI: 10.1007/s000660050044
  17. 17. Li X et al. Shared decision-making in breast reconstruction for breast cancer patients: A scoping review. Patient Preference and Adherence. 2021;15:2763-2781. DOI: 10.2047/PPA.S335080
  18. 18. Galimberti V, Vicini E, Veronesi P. Nipple-sparing mastectomy: Review of aims, oncological safe and contraindications. Breast. 2017;34(Suppl. 1):S82-S84. DOI: 10.1016/jbreast.2017.06.034
  19. 19. Platt J et al. Does breast reconstruction after mastectomy for breast cancer affect overall survival? Long-term follow-up of a retrospective population-based cohort. Plastic and Reconstructive Surgery. 2015;135(3):468e-476e. DOI: 10.1097/PRS.0000000000001054
  20. 20. Panchal H, Matros E. Advances in breast reconstruction. Plastic and Reconstructive Surgery. 2017;140(5S):7S-13S. DOI: 10.1097/PRS.0000000000003941
  21. 21. Wei G, Kumar A, Lee MC, Wang X. Influential factors on risk-reduction mastectomy in a high-risk breast cancer population with genetic predispositions. Clinical Breast Cancer. 2021;21(4):e427-e433. DOI: 10.1016/j.clbc.2021.01.008
  22. 22. Yip CH, Newman LA. Guideline for management of hereditary breast cancer. American society of clinical oncology, American society for radiation oncology, and society of surgical oncology. JAMA Surgery. 2021;156:284-285. DOI: 10.1001/jamasurg.2020.6254
  23. 23. Yoshida R. Hereditary breast and ovarian cancer (HBOC): Review of its molecular characteristics, screening, treatment, and prognosis. Breast Cancer. 2021;28(6):1167-1180. DOI: 10.1007/s12282-020-01148-2
  24. 24. Tung NM, Boughey JC, Pierce LJ, Robson ME, Bedrosian I. Management of hereditary breast cancer: American society of clinical oncology, American society for radiation oncology, and society of surgical oncology guideline. Journal of Clinical Oncology. 2020;38:2080-2106. DOI: 10.1200/JCO.20.00299
  25. 25. Eisemann B, Spiegel A. Risk-reducing mastectomy and breast reconstruction: Indications and evidence for current management strategies. Review Clinical Plastic Surgery. 2018;45(1):129-136. DOI: 10.1016/j.cps.2017.08.013
  26. 26. Headon H, Kasem A, Mokbel K. The oncological safety of nipple-sparing mastectomy: A systematic review of the literature with a pooled analysis of 12,358 procedure. Archives of Plastic Surgery. 2016;43(4):328-338. DOI: 10.5999/aps.2016.43.4.328
  27. 27. Shammas RL, Cason RW, Sergesketter AR, Glener AD. Broadwater a comparison of surgical complications in patients undergoing delayed versus staged tissue-expander and free-flap breast reconstruction. Plastic and Reconstructive Surgery. 2021;148(3):501-509. DOI: 10.1097/PRS.0000000000008208
  28. 28. Matar DY, Wu M, Haug V, Orgill DP, Panayi AC. Surgical complications in immediate and delayed breast reconstruction: A systematic review and meta-analysis. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2022;75(11):4085-4095. DOI: 10.1016/j.bjps.2022.08.029
  29. 29. Kumbla PA, Ananthasekar S, Denney BD. Two-stage, prepectoral breast reconstruction: Standardized technique and outcomes. Analysis during first stage to reduce complications and ensure reliability. Annals of Plastic Surgery. 2021;86(6S Suppl 5):S482-S486. DOI: 10.1097/SAP.0000000000002700
  30. 30. Colwell AS, Taylor EM. Recent Advances in Implant-Based Breast Reconstruction. Plastic and Reconstructive Surgery. 2020;145(2):421e-432e. DOI: 10.1097/PRS.0000000000006510
  31. 31. Caputo GG, Vigato E, Rampino Cordaro E, Parodi PC, Governa M. Comparative study of patient outcomes between direct to implant and two-stage implant-based breast reconstruction after mastectomy. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2021;74(10):2573-2579. DOI: 10.1016/j.bjps.2021.03.058
  32. 32. Weinzierl A, Schmauss D, Brucato D, Harder Y. Implant-based breast reconstruction after mastectomy, from the subpectoral to the prepectoral approach: An evidence-based change of mind Journal of Clinical Medicine 2022;11(11):3079. DOI: 10.3390/jcm11113079
  33. 33. Rolph R, Farhadi J. The use of meshes and matrices in breast reconstruction. British Journal of Hospital Medicine (London, England). Aug 2018;79(8):454-459. DOI: 10.12968/hmed.2018.79.8.454
  34. 34. American Society of Plastic Surgeon. Supplement 2018. Breast reconstruction
  35. 35. Saldanha I, Broyles J, Adam G, Cao W, Bhuma M, Mehta S, et al. Autologous breast reconstruction after mastectomy for breast cancer: A systematic review. Plastic and Reconstructive Surgery. Global Open. 2022;10(3):e4181. DOI: 10.1097/GOX.0000000000001481
  36. 36. Costanzo D, Klinger M, Lisa A, Maione L, Battistini A, Vinci V. The evolution of autologous breast reconstruction. The Breast Journal. 2020;26(11):2223-2225. DOI: 10.1111/tbj.14025
  37. 37. Chang EI. Latest advancements in autologous breast reconstruction. Plastic and Reconstructive Surgery. 2021;147(1):111e-122e. DOI: 10.1097/PRS.0000000000007480
  38. 38. Toyserkani NM, Jørgensen MG, Tabatabaeifar S, Damsgaard T, Sørensen JA. Autologous versus implant-based breast reconstruction: A systematic review and meta-analysis of Breast-Q patient-reported outcomes. Journal of Plastic, Reconstructive & Aesthetic Surgery. 2020;73(2):278-285. DOI: 10.1016/j.bjps.2019.09.040
  39. 39. Piffer A, Aubry G, Cannistra C, Popescu N, Nikpayam M, Koskas M, et al. Breast reconstruction by exclusive lipofilling after total mastectomy for breast cancer: Description of the technique and evaluation of quality of life. Journal of Personalized Medicine. Feb 2022;12(2):153. DOI: 10.3390/jpm12020153
  40. 40. Chung J, Kim K, Jung S, Park S, Yoon E. Analysis of oncological safety of autologous fat grafting after immediate breast reconstruction. Gland Surgery. 2021;10(2):584-594. DOI: 10.21037/gs-20-645
  41. 41. Turner A, Abu-Ghname A, Davis MJ, Winocour SJ, Hanson SE, Chu CK. Fat grafting in breast reconstruction. Seminars in Plastic Surgery. 2020;34:17-23. DOI: 10.1055/s-0039-1700959
  42. 42. Kellou K, Lequesne J, Georgescu D, De Gournay E, Breard H, et al. Limitations of breast reconstruction using exclusive lipofilling: A retrosoective study over 10 years. Gynecologie, Obstetrique, Fertilite & Senologie. 2019;47:347-351. DOI: 10.1016/j.gofs.2019.02.007
  43. 43. Mestak O et al. Breast reconstruction after bilateral mastectomy using the BRAVA expansion system and fat grafting. Plastic and Reconstructive Surgery Global Open. Nov 2013;1(8);e71.DOI: 10.1097/GOX.00000000000022
  44. 44. Alessandri Bonetti M, Carbonaro R, Borelli F, Amendola F, Cottone G, Mazzocconi L, et al. Outcomes in hybrid breast reconstruction: A systematic review. Medicina (Kaunas, Lithuania). 2022;58(9):1232. DOI: 10.3390/medicina58091232
  45. 45. Kaufman CS. Increasing role of oncoplastic surgery for breast cancer. Current Oncology Reports. 2019;21(12):111. DOI: 10.1007/s11912-019-0860-9
  46. 46. Salibian AA, Olson B, Shauly O, Patel KM. Oncoplastic breast reconstruction: Principles, current techniques, and future directions. Journal of Surgical Oncology. 2022;126(3):450-459. DOI: 10.1002/jso.26897
  47. 47. The US Food and Drug Administration. Medical Device Reports of Breast Implant-Associated Anaplastic Large Cell Lymphoma. 2022. Available from: www.fda.gov
  48. 48. The US Food and Drug Administration Breast Implants: Reports of Squamous Cell Carcinoma and Various Lymphomas in Capsule Around Implants: FDA Safety Communication. 2022. Available from: www.fda.gov
  49. 49. McCormick B. Breast journal 2020 special issue: Post-mastectomy radiation: Tracking changes in the standard of care over 25 years. The Breast Journal. 2020;26(1):55-58. DOI: 10.1111/tbj.13726
  50. 50. Weber P et al. Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy. The Breast. DOI: 10.1016/j.breast.2022.03.008
  51. 51. Paolini G, Firmani G, Briganti F, Sorotos M, Santanelli di Pompeo F. Guiding nipple-areola complex reconstruction: Literature review and proposal of a new decision-making algorithm. Plastic Surgery. 2021;45(3):933-945. DOI: 10.1007/s00266-020-02047-9
  52. 52. Liliav B et al. Single-stage nipple-areolar complex reconstruction technique, outcomes and patient satisfaction. Annals of Plastic Surgery. Nov 2014;73(5):492-497. DOI: 10.1097/ SAP.0b013e318276dac0

Written By

Benjamin Liliav and Luis Torres-Strauss

Submitted: 05 November 2022 Reviewed: 08 November 2022 Published: 06 December 2022